Real-time cell cycle imaging during melanoma growth, invasion, and drug response

Melanoma never says die

(2014) Nikolas K. Haass et al.   EXPERIMENTAL DERMATOLOGY

A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy

(2013) P.L. Tong et al.   BRITISH JOURNAL OF DERMATOLOGY

Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching

(2013) Daniel S. Widmer et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines

(2013) A Vultur et al.   ONCOGENE

Melanoma’s connections to the tumour microenvironment

(2013) Johanna M. Brandner et al.   PATHOLOGY

DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma

(2013) Sandra Pavey et al.   Pigment Cell & Melanoma Research

Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2

(2013) M. P. O'Connell et al.   Cancer Discovery

An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids

(2012) Takahisa Anada et al.   BIOMATERIALS

Melanoma: from mutations to medicine

(2012) H. Tsao et al.   GENES & DEVELOPMENT

Intravital multiphoton imaging of immune responses in the mouse ear skin

(2012) Jackson LiangYao Li et al.   Nature Protocols

Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies

(2012) Shubha Bagrodia et al.   Pigment Cell & Melanoma Research

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737

(2011) K. M. Lucas et al.   CLINICAL CANCER RESEARCH

Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling

(2011) Nikhil Wagle et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer invasion and resistance: interconnected processes of disease progression and therapy failure

(2011) Stephanie Alexander et al.   TRENDS IN MOLECULAR MEDICINE

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

(2010) Alexander Roesch et al.   CELL

Moving Targets That Drive Cancer Progression

(2010) Mark Shackleton   NEW ENGLAND JOURNAL OF MEDICINE

Cancer stem cells versus phenotype-switching in melanoma

(2010) Keith S. Hoek et al.   Pigment Cell & Melanoma Research

PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas

(2010) John T. Lee et al.   Pigment Cell & Melanoma Research

A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status

(2010) Marie C. Zipser et al.   Pigment Cell & Melanoma Research

Melanocytes: From Morphology to Application

(2009) A. Santiago-Walker et al.   SKIN PHARMACOLOGY AND PHYSIOLOGY

In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States

(2008) K. S. Hoek et al.   CANCER RESEARCH

Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression

(2008) Asako Sakaue-Sawano et al.   CELL

The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel

(2008) N. K. Haass et al.   CLINICAL CANCER RESEARCH

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

(2008) J. Tsai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Melanoma and the tumor microenvironment

(2008) Jessie Villanueva et al.   Current Oncology Reports